Sage Therapeutics
SAGE
#7026
Rank
$0.54 B
Marketcap
$8.68
Share price
0.00%
Change (1 day)
8.50%
Change (1 year)

Sage Therapeutics (SAGE) - Total debt

Total debt on the balance sheet as of March 2025 : $11.85 Million USD

According to Sage Therapeutics 's latest financial reports the company's total debt is $11.85 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Sage Therapeutics - Total debt on balance sheet (from 2018 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$11.83 M129.16%
2023-12-31$5.16 M-57.43%
2022-12-31$12.13 M-34.17%
2021-12-31$18.43 M-34.41%
2020-12-31$28.1 M-24.24%
2019-12-31$37.09 M
2018-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Regulus Therapeutics
RGLS
$1.4 M-88.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Eagle Pharmaceuticals
EGRX
$71.61 M 504.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Horizon Therapeutics
HZNP
$2.55 B 21,472.84%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
$0.22 B 1,788.28%๐Ÿ‡บ๐Ÿ‡ธ USA